Rapid Therapeutic Science Laboratories
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Rapid Therapeutic Science Laboratories generated cash of -$2,209,131, which is less than the previous year. Cash used in financing activities reached the amount of $2,195,000 last year. Net change in cash is therefore -$306,662.

Cash Flow

Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL): Cash Flow
2016 -10.74K 0 10K
2018 -129.85K -38.62K 173.37K
2020 -106.66K -155.07K 95.7K
2021 -2.20M -292.53K 2.19M

RTSL Cash Flow Statement (2015 – 2021)

2021 2019 2017 2015
Cash at beginning of period
499.14K12.29K7.39K9.98K
Operating activities
Net income
-2.86M-348.84K-2.55M-12.02K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
55.85K37.5K16.39K0
Stock-based compensation expense
20K43K7.16K0
Deferred income tax benefit 20K43K7.16K0
Changes in operating assets and liabilities:
Accounts receivable, net
05.87K00
Inventories
11.75K-5.87K00
Accounts payable
82.18K4.70K14.65K1.27K
Cash generated by operating activities
-2.20M-106.66K-129.85K-10.74K
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
-292.53K-155.07K-38.62K0
Acquisitions Net
0000
Cash generated by investing activities
-292.53K-155.07K-38.62K0
Financing activities
Common Stock Issued
585K75K1K0
Payments for dividends
0000
Repurchases of common stock
0000
Repayments of term debt
1.61M000
Cash used in financing activities
2.19M95.7K173.37K10K
Net Change In Cash
-306.66K-10.96K4.90K-743
Cash at end of period
192.48K1.33K12.29K9.23K
Data sourceData sourceData sourceData source